A new draft proposal for the Innovative Health Initiative (the next European Partnership for Health Innovation and successor to the IMI) was released last month and proposes to establish an Innovation Panel. The new panel would be composed of representatives of industry, member states and stakeholders and help to co-design the activities of the partnership.
Stakeholders will be selected through calls for expression of interest and they will help set priorities and activities of the partnership and support the governance board. The panel will play an important role and help to “…to identify and review potential call topics, ensuring that they adequately address public health interest and needs of end-users” (See Innovative Health Initiative Proposal p22).
The BioMed Alliance and other stakeholders had been calling for quite some time for greater stakeholder involvement in the partnerships for health to ensure that the input of researchers, clinicians and patients is better incorporated.
